av/taysha-gene-therapies--big.svg

NASDAQ:TSHA

Taysha GTx

  • Stock

USD

Last Close

1.42

08/11 21:00

Market Cap

455.12M

Beta: 1.17

Volume Today

2.74M

Avg: 417.73K

PE Ratio

−0.89

PFCF: −5.58

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-4.46M
-
-60.01M
1,245.54%
-174.52M
190.82%
-166.01M
4.88%
-111.57M
32.80%
depreciation and amortization
9K
-
492K
5,366.67%
1.17M
138.21%
1.37M
16.98%
deferred income tax
2.29M
-
stock based compensation
3.35M
-
18.18M
442.16%
18.04M
0.78%
7.91M
56.19%
change in working capital
135K
-
-111K
182.22%
28.67M
25,926.13%
18.52M
35.40%
-2.29M
112.39%
accounts receivables
inventory
accounts payables
1.96M
-
14.49M
639.11%
-7.80M
153.84%
-2.29M
70.59%
other working capital
135K
-
-2.07M
1,634.81%
14.17M
784.03%
26.32M
85.72%
2.29M
91.28%
other non cash items
4.46M
-
26.03M
483.63%
10.14M
61.05%
39.89M
293.48%
31.57M
20.87%
net cash provided by operating activities
135K
-
-30.73M
22,862.22%
-117.04M
280.88%
-88.39M
24.48%
-73.02M
17.39%
investments in property plant and equipment
-9.08M
-
-21.55M
137.33%
-24.87M
15.38%
-3.87M
84.44%
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
-61K
-
-3.48M
5,609.84%
net cash used for investing activites
-9.08M
-
-21.55M
137.33%
-24.93M
15.66%
-7.35M
70.51%
debt repayment
-1.67M
-
-39.96M
2,288.34%
common stock issued
165.85M
-
-360K
100.22%
53.24M
14,890%
140.29M
163.49%
common stock repurchased
dividends paid
other financing activites
126.88M
-
79.40M
37.42%
-1.15M
101.44%
-3.90M
239.76%
net cash used provided by financing activities
291.06M
-
39.08M
86.57%
52.10M
33.30%
136.39M
161.81%
effect of forex changes on cash
net change in cash
135K
-
251.25M
186,013.33%
-99.51M
139.61%
-61.22M
38.48%
56.02M
191.51%
cash at beginning of period
251.25M
-
151.74M
39.61%
90.52M
40.35%
cash at end of period
135K
-
251.25M
186,013.33%
151.74M
39.61%
90.52M
40.35%
146.54M
61.89%
operating cash flow
135K
-
-30.73M
22,862.22%
-117.04M
280.88%
-88.39M
24.48%
-73.02M
17.39%
capital expenditure
-9.08M
-
-21.55M
137.33%
-24.87M
15.38%
-3.87M
84.44%
free cash flow
135K
-
-39.81M
29,589.63%
-138.60M
248.13%
-113.26M
18.28%
-76.89M
32.11%

All numbers in USD (except ratios and percentages)